MTOR: From growth signal integration to cancer, diabetes and ageing

3.5kCitations
Citations of this article
2.8kReaders
Mendeley users who have this article in their library.
Get full text

Abstract

In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors. Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt. In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and ageing. © 2011 Macmillan Publishers Limited. All rights reserved.

Cite

CITATION STYLE

APA

Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011, January). MTOR: From growth signal integration to cancer, diabetes and ageing. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/nrm3025

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free